The First Three Years of Buprenorphine in the United States: Experience to Date and Future Directions
- 1 June 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 1 (2) , 62-67
Abstract
Buprenorphine, primarily as the buprenorphine/naloxone combination, has been available in the United States for office and specialty treatment program-based care since 2003. The existing evidence, collected primarily from federal sources, indicates that access to this type of treatment has expanded, that more than 50% of the 12,000 physicians able to provide this care are not addiction specialists, that buprenorphine diversion is low, that physician scrutiny by federal agents is infrequent, and among those receiving treatment patient acceptance is high. Implementation has been slowed because of physician training and support needs, reimbursement, and limits on the number of patients each physician can treat. As a result there are geographic variations in access and unmet treatment needs. The United States Congress has moved twice to loosen numerical limitations, now allowing each physician to treat up to 100 patients. Future research and evaluation are needed to ensure that opioid-dependent patients receive optimal care with buprenorphine.Keywords
This publication has 10 references indexed in Scilit:
- Buprenorphine Use: The International ExperienceClinical Infectious Diseases, 2006
- Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United StatesClinical Infectious Diseases, 2006
- A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical CareClinical Infectious Diseases, 2006
- Experiences of a National Sample of Qualified Addiction Specialists Who Have and Have Not Prescribed Buprenorphine for Opioid DependenceJournal of Addictive Diseases, 2006
- Training HIV Physicians to Prescribe Buprenorphine for Opioid DependenceSubstance Abuse, 2006
- Potential for Abuse of Buprenorphine in Office-Based Treatment of Opioid DependenceNew England Journal of Medicine, 2005
- Implementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation TrialThe American Journal on Addictions, 2004
- French Field Experience with BuprenorphineThe American Journal on Addictions, 2004
- New Federal Initiatives To Enhance the Medical Treatment of Opioid DependenceAnnals of Internal Medicine, 2002
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978